CLX Clorox (CLX) Insider Trading, Ownership & Congress Trades
Consumer Goods · Specialty cleaning, polishing and sanitation preparations · CIK 0000021076
Congress · 2
Funds added, last quarter
549
13F, latest reported quarter
What the filings say about CLX
Insiders, 180 days
+$429.1K net bought
1 buyer
Congress, 1 year
2 bought · 2 sold
Latest: sale, 2026-05-15
Clorox insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, CLOROX CO /DE/ insiders bought a net $429.1K of stock across 16 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Nov 21, 2025.
- +5.4% median (+5.4% mean) 90-day return after 2 previous buys.
- The trade is 27.8% of the 18,000 shares held after it.
- No other insider bought within 30 days.
- 549 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Breber Pierre R bought about $429.1K of CLX on May 5, 2026; 549 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on May 7, 2025.
- The trade is 30.8% of the 13,000 shares held after it.
- No other insider bought within 30 days.
- 549 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Breber Pierre R bought about $416.5K of CLX on Nov 21, 2025; 549 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on May 9, 2022.
- The trade is 27.7% of the 54,221 shares held after it.
- No other insider sold within 30 days.
- 549 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP - Chief Operating Officer Reynolds Eric H sold about $1.9M of CLX on Sep 4, 2025, the largest insider sale at the company on our record; 549 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 100.0% of the 4,000 shares held after it.
- No other insider bought within 30 days.
- 549 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Breber Pierre R bought about $546.3K of CLX on May 7, 2025, the largest insider purchase at the company on our record; 549 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Mar 10, 2025.
- The trade is 2.8% of the 26,305 shares held after it.
- No other insider sold within 30 days.
- 549 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP - Chief People Officer Marriner Kirsten sold about $110.0K of CLX on Mar 11, 2025; 549 funds added in the latest 13F quarter.16 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net +$429.1K over 180 days
more than 92% of Consumer Goods
Congress
2 members bought in the last year
more than 54% of Consumer Goods
Funds
549 funds bought in last quarter
more than 93% of Consumer Goods
Revenue
+0.2% year over year
below 58% of Consumer Goods
Margin
8.5% net margin
more than 80% of Consumer Goods
Buybacks
$256.0M repurchased, FY to 2026-03-31
more than 86% of Consumer Goods
Short interest
9.6% of the float short (float per yahoo 2026-10-26) · 3.5 days to cover · settled 2026-09-30
more than 85% of Consumer Goods
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch CLX
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-22.8%12M
Insider buy
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns CLX: institutional holders (13F)
13F holdings, latest reported quarter
10,044,423 sh
$958.6M
8,432,523 sh
$804.8M
7,896,390 sh
$753.6M
6,010,072 sh
$573.6M
5,799,952 sh
$553.5M
Congress trades in CLX
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2026-05-15 · disclosed 24 days later
$1,001 - $15,000
Bought 2025-12-19 · disclosed 24 days later
$1,001 - $15,000
Sold 2025-11-12 · disclosed 33 days later
$1,001 - $15,000
Sold 2025-10-31 · disclosed 21 days later
$1,001 - $15,000
Sold 2025-10-30 · disclosed 22 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
CLX planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
CLX mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Nuance Concentrated Value Fund
$4.3M position · as of 2026-07-31
10.2%
Nuance Mid Cap Value Fund
$15.5M position · as of 2026-07-31
5.3%
Invesco S&P 500 Equal Weight Consumer Staples ETF
$7.2M position · as of 2026-07-31
2.9%
Cambiar SMID Fund
$974.4K position · as of 2026-07-31
2.5%
Jensen Quality Mid Cap Fund
$2.2M position · as of 2026-05-31
2.3%
VictoryShares Dividend Accelerator ETF
$5.5M position · as of 2026-06-30
2.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Clorox Employees' Political Action Committee
Cycle 2026 · $1K spent
$0
Federal Election Commission, matched by the PAC's connected organisation
Executive pay vs shareholder return · Ms.
Rendle
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$14.0M
$2.6M
$6.9M
-37%
+17%
2024
$13.3M
$10.4M
$5.2M
-24%
+22%
2023
$12.7M
$6.2M
$4.0M
-17%
+25%
2022
$11.6M
$19.4M
$4.0M
-6%
+12%
2021
$8.5M
$7.1M
$3.2M
-19%
+5%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $429.1K bought by insiders over 180 days, 549 funds added last quarter, 2 House member(s) bought in 12 months, disclosed weeks after the trade. Each figure is a federal filing, dated the day it went public.
CLX financials
Revenue growth
+0.2%
XBRL, annual
Net margin
8.5%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$6.8B
four quarters, 2025-04-01 to 2026-03-31
Revenue, TTM CLX
| FY Jun 2026 | $6.8B |
| FY Jun 2025 | $7.1B |
| FY Jun 2024 | $7.1B |
| FY Jun 2023 | $7.4B |
| FY Jun 2022 | $7.1B |
| Jun 2026 | n/a |
| Mar 2026 | $1.7B |
| Dec 2025 | $1.7B |
| Sep 2025 | $1.4B |
| Jun 2025 | $2.0B |
| Mar 2025 | $1.7B |
| Dec 2024 | $1.7B |
| Sep 2024 | $1.8B |
At each fiscal year end
Single quarter
Net margin, TTM
+8.9%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM CLX
| FY Jun 2026 | +8.9% |
| FY Jun 2025 | +11.6% |
| FY Jun 2024 | +4.1% |
| FY Jun 2023 | +2.2% |
| FY Jun 2022 | +6.6% |
| Jun 2026 | n/a |
| Mar 2026 | +11.2% |
| Dec 2025 | +9.4% |
| Sep 2025 | +5.6% |
| Jun 2025 | +17.4% |
| Mar 2025 | +11.2% |
| Dec 2024 | +11.4% |
| Sep 2024 | +5.6% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$380.0M
operating cash flow minus capex, 2025-04-01 to 2026-03-31
Free cash flow, TTM CLX
| FY Jun 2026 | $380.0M |
| FY Jun 2025 | $761.0M |
| FY Jun 2024 | $483.0M |
| FY Jun 2023 | $930.0M |
| FY Jun 2022 | $535.0M |
| Jun 2026 | n/a |
| Mar 2026 | -$165.0M |
| Dec 2025 | $269.0M |
| Sep 2025 | $57.0M |
| Jun 2025 | $219.0M |
| Mar 2025 | $233.0M |
| Dec 2024 | $127.0M |
| Sep 2024 | $182.0M |
At each fiscal year end
Single quarter
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Debt to equity CLX
| FY Jun 2026 | n/a |
| FY Jun 2025 | 7.74x |
| FY Jun 2024 | 7.56x |
| FY Jun 2023 | 11.26x |
| FY Jun 2022 | 4.45x |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | 7.74x |
| Mar 2025 | 91.96x |
| Dec 2024 | n/a |
| Sep 2024 | 41.37x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.23x
TTM operating cash flow over long-term 2026-03-31 plus current 2025-06-30 (12 months older than the period end)
Cash flow to debt CLX
| FY Jun 2026 | 0.23x |
| FY Jun 2025 | 0.39x |
| FY Jun 2024 | 0.28x |
| FY Jun 2023 | 0.47x |
| FY Jun 2022 | 0.32x |
| Jun 2026 | 0.23x |
| Mar 2026 | 0.23x |
| Dec 2025 | 0.40x |
| Sep 2025 | 0.34x |
| Jun 2025 | 0.39x |
| Mar 2025 | 0.41x |
| Dec 2024 | 0.37x |
| Sep 2024 | 0.36x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
average equity is zero or negative
Return on equity CLX
| FY Jun 2026 | n/a |
| FY Jun 2025 | +253.9% |
| FY Jun 2024 | +106.6% |
| FY Jun 2023 | +41.5% |
| FY Jun 2022 | +97.4% |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | +4,237% |
| Jun 2025 | +253.9% |
| Mar 2025 | +1,197% |
| Dec 2024 | +7,817% |
| Sep 2024 | +3,209% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+10.1%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on assets CLX
| FY Jun 2026 | +10.1% |
| FY Jun 2025 | +14.6% |
| FY Jun 2024 | +5.0% |
| FY Jun 2023 | +2.7% |
| FY Jun 2022 | +7.5% |
| Jun 2026 | +10.1% |
| Mar 2026 | +12.9% |
| Dec 2025 | +13.7% |
| Sep 2025 | +14.6% |
| Jun 2025 | +14.6% |
| Mar 2025 | +12.5% |
| Dec 2024 | +8.2% |
| Sep 2024 | +6.4% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital CLX
| FY Jun 2026 | n/a |
| FY Jun 2025 | n/a |
| FY Jun 2024 | n/a |
| FY Jun 2023 | n/a |
| FY Jun 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed CLX
| FY Jun 2026 | n/a |
| FY Jun 2025 | n/a |
| FY Jun 2024 | n/a |
| FY Jun 2023 | n/a |
| FY Jun 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
14.08x
close 2026-10-26 over four quarters of diluted EPS, 2025-04-01 to 2026-03-31
P/E, trailing CLX
| FY Jun 2026 | 15.49x |
| FY Jun 2025 | 18.42x |
| FY Jun 2024 | 60.92x |
| FY Jun 2023 | 133.65x |
| FY Jun 2022 | 37.80x |
| Jun 2026 | 15.49x |
| Mar 2026 | 16.82x |
| Dec 2025 | 16.48x |
| Sep 2025 | 19.36x |
| Jun 2025 | 18.42x |
| Mar 2025 | 26.44x |
| Dec 2024 | 44.37x |
| Sep 2024 | 56.76x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$11.8B
market value at close 2026-10-26 on 2026-04-16 shares, plus long-term 2026-03-31 plus current 2025-06-30 (12 months older than the period end), minus cash 2026-03-31
Enterprise value CLX
| FY Jun 2026 | $12.8B |
| FY Jun 2025 | $17.1B |
| FY Jun 2024 | $19.2B |
| FY Jun 2023 | $21.8B |
| FY Jun 2022 | $19.6B |
| Jun 2026 | $12.8B |
| Mar 2026 | $13.8B |
| Dec 2025 | $14.6B |
| Sep 2025 | $17.4B |
| Jun 2025 | $17.1B |
| Mar 2025 | $20.4B |
| Dec 2024 | $22.3B |
| Sep 2024 | $22.4B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+3.6%
TTM free cash flow over market value at close 2026-10-26
FCF yield CLX
| FY Jun 2026 | +3.3% |
| FY Jun 2025 | +5.1% |
| FY Jun 2024 | +2.8% |
| FY Jun 2023 | +4.7% |
| FY Jun 2022 | +3.1% |
| Jun 2026 | +3.3% |
| Mar 2026 | +3.0% |
| Dec 2025 | +6.3% |
| Sep 2025 | +4.2% |
| Jun 2025 | +5.1% |
| Mar 2025 | +4.4% |
| Dec 2024 | +3.5% |
| Sep 2024 | +3.3% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
1.33x
P/E over trailing EPS growth of 11%: four quarters to 2026-03-31 against the four to 2025-03-31
PEG, trailing CLX
| FY Jun 2026 | 1.46x |
| FY Jun 2025 | 0.10x |
| FY Jun 2024 | 0.69x |
| FY Jun 2023 | n/a |
| FY Jun 2022 | n/a |
| Jun 2026 | 1.46x |
| Mar 2026 | 1.59x |
| Dec 2025 | 0.25x |
| Sep 2025 | 0.16x |
| Jun 2025 | 0.10x |
| Mar 2025 | 0.14x |
| Dec 2024 | 0.09x |
| Sep 2024 | 0.18x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2026-06 | 2025-06 | 2024-06 | 2023-06 | |
|---|---|---|---|---|
| Revenue | n/a | $7.1B | $7.1B | $7.4B |
| Gross profit | n/a | $3.2B | $3.0B | $2.9B |
| Net income | $601.0M | $824.0M | $292.0M | $161.0M |
| EPS (diluted) | n/a | 6.52 | 2.25 | 1.20 |
| Operating cash flow | n/a | $981.0M | $695.0M | $1.2B |
| Cash | n/a | $167.0M | $202.0M | $367.0M |
| Long-term debt | n/a | $2.5B | $2.5B | $2.5B |
| Buybacks | n/a | $332.0M | $0 | $0 |
| Dividends paid | n/a | $602.0M | $595.0M | $583.0M |
SEC XBRL, fiscal years, as known on 2026-10-28
CLX Stock Sonar score 5/7 axes
Find similar shapesCompareCLX ranks highest on insider conviction (76th percentile) and institutional and government (67th), and lowest on risk and compliance (15th), among Consumer Goods peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CLX filings, in plain words
Are Clorox insiders buying or selling CLX?
In the 180 days to 2026-10-28, Clorox insiders were net buyers, a net $429.1K across purchases and sales reported on Form 4, by 1 buyer.
Have members of Congress traded CLX?
Yes. In the year to 2026-10-28, 2 House members disclosed buying CLX and 2 House members disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-05-15.
Read the full summary
In the 180 days to 2026-10-28, Clorox insiders were net buyers of CLX, a net $429.1K across purchases and sales reported on Form 4 by 1 buyer. In the year to 2026-10-28, 2 members of Congress disclosed buying CLX and 2 members disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-05-15. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
